DIAGNOSTIC VALUE OF PROCALCITONIN FOR DETECTION OF SEPSIS IN THE EMERGENCY DEPARTMENT OF TAM ANH GENERAL HOSPITAL, HO CHI MINH CITY

Minh Trí Tôn1, , Thị Oanh Đặng2, Hoàng Khương Nguyễn2, Gia Cường Lý2
1 Bệnh viện Đa khoa Tâm Anh Quận 8
2 Bệnh viện Đa khoa Tâm Anh TP Hồ Chí Minh

Main Article Content

Abstract

Objective: To evaluate the diagnostic value of procalcitonin (PCT) for early detection of sepsis in the Emergency Department of Tam Anh General Hospital, Ho Chi Minh City.


Subjects and Methods: A retrospective cross-sectional diagnostic study was conducted on 774 adult patients who underwent PCT testing in the Emergency Department from January 2025 to December 2025 and had sufficient data for Sepsis-3 assessment. Diagnostic performance was assessed using ROC analysis, and the optimal cut-off value was determined using the Youden index.


Results: Among 774 patients, 262 (33.9%) were diagnosed with sepsis. Median PCT levels were significantly higher in the sepsis group than in the non-sepsis group (2.62 ng/mL vs 0.13 ng/mL; p<0.001). PCT demonstrated good diagnostic performance with an AUC of 0.897 (95% CI: 0.872–0.919), outperforming CRP (AUC = 0.682; 95% CI: 0.637–0.731) and white blood cell count (AUC = 0.610; 95% CI: 0.553–0.667). The optimal cut-off value was 0.32 ng/mL, with sensitivity of 84.7%, specificity of 77.1%, positive predictive value of 65.5%, and negative predictive value of 90.8%. PCT showed weak positive correlations with SOFA (ρ = 0.168; p = 0.006) and SOFA-2 scores (ρ = 0.147; p = 0.017).


Conclusion: Procalcitonin demonstrated good diagnostic value for early detection of sepsis in the Emergency Department and outperformed CRP and white blood cell count. PCT may support early identification of suspected sepsis patients and initial risk stratification in emergency clinical practice.

Article Details

References

1. Becker KL, Nylén ES, White JC, Müller B, Snider RH. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis. J Clin Endocrinol Metab. 2004;89(4):1512-1525.
2. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of procalcitonin for sepsis diagnosis in critically ill patients. J Infect Chemother. 2012;18(1):50-54.
3. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47:1181-1247.
4. Guan J, Lin Z, Zhang J, et al. Procalcitonin levels in Sepsis and septic shock. Medicine (Baltimore). 2020;99(25):e20524.
5. Meisner M. Update on Procalcitonin Measurements. Ann Lab Med. 2014;34(4):263-273.
6. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions. BMC Med. 2011;9:107.
7. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
8. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for Sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.